SSRI Antidepressants Increase Risk Of Intracranial Hemorrhage

FakeNews
Source: NoMoreFakeNews.com | JonRappoport.wordpress.com
By: Jon Rappoport
April 30, 2017

From healthline.com: “Intracranial hemorrhage (ICH) refers to acute bleeding inside your skull or brain. It’s a life-threatening emergency. You should go to the emergency room right away or call 911 if you think you or someone you know is experiencing ICH.”

The public has learned about the increased risk of suicide and violent behavior (including murder) stemming from the use of SSRI antidepressants. Now there is more:

Psychiatric News reports (4/7/17): “A study published in February in JAMA Neurology has found that patients taking antidepressants that are strong inhibitors of serotonin reuptake (SSRIs) may be at an increased risk for intracranial hemorrhage, particularly during the first month of use…”

“The results showed that compared with patients taking [the older] tricyclic antidepressants, patients being treated with SSRIs had a 17 percent increased risk of experiencing an intracranial hemorrhage. The risk was highest during the first 30 days the patients were taking the medications.”

SSRIs include: Celexa; Prozac; Paxil; Zoloft; Lexapro; Luvox.

Here are quotes from other Psychiatric News articles about SSRI use and bleeding:

“Physicians prescribing selective serotonin-reuptake inhibitors (SSRIs) should make patients aware of the possibility of gastrointestinal bleeding, especially if they have pre-existing risk factors or are taking other drugs that increase risk, said a University of Pennsylvania psychiatrist.”

From a January 2014 study in the American Journal of Psychiatry—“Short-term SSRI use—even as little as 7 days—elevated the risk of upper gastrointestinal bleeding, especially in male patients. Just as with NSAIDs and aspirin, physicians should carefully monitor for this side effect.”

Note: Suddenly withdrawing from these drugs can be very dangerous. Psychiatrist Peter Breggin publishes this warning: “Most psychiatric drugs can cause withdrawal reactions, sometimes including life-threatening emotional and physical withdrawal problems. In short, it is not only dangerous to start taking psychiatric drugs, it can also be dangerous to stop them. Withdrawal from psychiatric drugs should be done carefully under experienced clinical supervision. Methods for safely withdrawing from psychiatric drugs are discussed in Dr. Breggin’s new book, Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients and Their Families.”

Read More At: JonRappoport.wordpress.com
_______________________________________________________________

Jon Rappoport

The author of three explosive collections, THE MATRIX REVEALED, EXIT FROM THE MATRIX, and POWER OUTSIDE THE MATRIX, Jon was a candidate for a US Congressional seat in the 29th District of California. He maintains a consulting practice for private clients, the purpose of which is the expansion of personal creative power. Nominated for a Pulitzer Prize, he has worked as an investigative reporter for 30 years, writing articles on politics, medicine, and health for CBS Healthwatch, LA Weekly, Spin Magazine, Stern, and other newspapers and magazines in the US and Europe. Jon has delivered lectures and seminars on global politics, health, logic, and creative power to audiences around the world. You can sign up for his free NoMoreFakeNews emails here or his free OutsideTheRealityMachine emails here.

Advertisements

Researchers Demand American Psychiatric Association Retract Study That Fabricated Benefits Of Antidepressants, Covered Up Adverse Health Effects

Celexa

Source: NaturalNews.com
Julie Wilson
August 9, 2016

A large group of medical doctors, psychiatrists and researchers are demanding that the American Psychiatric Association retract a shady study that relied upon industry influence to determine the effectiveness of an antidepressant that’s widely prescribed among children and teens.

The study, published more than a decade ago in the American Journal of Psychiatry, touted the benefits of Celexa in younger populations suffering from depression.

However, a recent analysis of the research found “gross misrepresentations” about the safety and effectiveness of the drug, including the fact that Celexa worked no better than the placebo.

Study showing benefits of Celexa in children was written by the drug’s maker

The researchers say that the study reflected the “pervasive influence” of the marketing objectives of Forest Laboratories, the Celexa manufacturer, adding that the “scientific” manuscript was “written primarily for marketing purposes and only secondarily as a peer-reviewed journal.”

In other words, the study was totally fabricated to extend the consumer base for Celexa to children and teens, the fastest growing demographic for which antidepressants are prescribed.

The analysis revealed that the study was written by none other than ghost writers employed by Forest Laboratories who “seriously misrepresented” the data about the drug’s safety and efficacy.

“Forest’s own internal documents disclosed in litigation show that company staff were aware that there were serious problems with the conduct of this trial but concealed the problems in advancing their commercial objectives,” said the researchers.

As reported by Stat News, “Procedural deviations in the study were not reported; negative outcomes were not reported; [and] side effects were misleadingly analyzed.”

Fabricated study continues to be cited by the pharmaceutical industry

The researchers’ letter demanding a retraction is dated August 1, 2016, and addressed to Dr. Maria Oquendo, president of the American Psychiatric Association. It asks Oquendo to urge the current editor of the American Journal of Psychiatry to issue a retraction.

“Our main concern is that children and adolescents are continuing to be at risk of harm unnecessarily because well-intentioned physicians have been misled,” they wrote.

“We believe that the unretracted … article represents a stain on the high standard of the American Journal of Psychiatry (AJP) and the American Psychiatric Association (APA). Neither the AJP nor the APA can claim to be a leader in scientific research.”

New research finds antidepressants totally ineffective and dangerous for children

The revelations come roughly two months after a groundbreaking report revealed that most antidepressants marketed for children and teens are not only ineffective, but downright dangerous.

The research, published in The Lancet, reports that out of 14 antidepressants, only one (Prozac) provided depression relief for children and teens. Other antidepressants such as Effexor increased the risk of suicidal thoughts and suicide attempts in younger populations.

The study is the most comprehensive analysis ever conducted regarding antidepressant use among children and teens.

Supermodel says antidepressants made her a ‘sociopath’

The adverse effects of antidepressants continue to be disclosed by both physicians and patients alike. English fashion model Cara Delevingne recently told Britain’s Esquire magazine that antidepressants turned her into a “sociopath.”

Delevingne, who took the drugs for two years as a teenager, said she lost all feelings, and was “just numb” until she stopped taking them.

“I didn’t feel s**t. It was horrible. I was like a sociopath. When something was funny I would go, ‘Ha ha!’ just because other people laughed, but then I’d stop immediately because I wasn’t really very good at faking it.”

Read More At: NaturalNews.com
_______________________________________________________________

Sources:

FreePDFHosting.com[PDF]

StatNews.com

CBSNews.com

CaraDelevingne.Esquire.co.uk

Science.NaturalNews.com